| Oct 31 |
Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
|
| Oct 22 |
Quoin Pharmaceuticals Announces Further International Expansion of Ongoing Clinical Trials for Netherton Syndrome
|
| Oct 17 |
Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
|
| Sep 9 |
Quoin Pharmaceuticals announces insider share purchases
|
| Sep 9 |
Quoin Pharmaceuticals Announces Insider Share Purchases by Co-Founders CEO and COO
|
| Aug 22 |
QNRX: Assessing QRX003 For Multiple Conditions; Opening International Netherton Syndrome Clinical Sites
|
| Aug 8 |
Quoin Pharmaceuticals reports Q2 results
|
| Aug 8 |
Quoin Pharmaceuticals Provides Corporate Update and Announces Second Quarter 2024 Financial Results
|
| Aug 6 |
Quoin Pharmaceuticals to Initiate Clinical Study for Peeling Skin Syndrome
|
| Aug 1 |
Quoin Pharmaceuticals to Announce Second Quarter 2024 Financial Results on Thursday, August 8, 2024
|
